Spinal cord glioblastoma: 25years of experience from a single institution
Yanamadala V, Koffie R, Shankar G, Kumar J, Buchlak Q, Puthenpura V, Frosch M, Gudewicz T, Borges L, Shin J. Spinal cord glioblastoma: 25years of experience from a single institution. Journal Of Clinical Neuroscience 2016, 27: 138-141. PMID: 26755453, DOI: 10.1016/j.jocn.2015.11.011.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedChemoradiotherapyCombined Modality TherapyDNA MethylationFemaleGlioblastomaHumansKarnofsky Performance StatusMaleMiddle AgedNeoplasm ProteinsNeoplasm Recurrence, LocalProto-Oncogene Proteins B-rafRecovery of FunctionSpinal Cord NeoplasmsSurvival AnalysisTreatment OutcomeTumor Suppressor Protein p53ConceptsHigh-grade spinal cord gliomasSpinal cord gliomasKarnofsky performance statusFunctional statusAmerican Spine Injury Association (ASIA) scorePost-operative functional statusPost-operative radiationSubtotal surgical resectionSubset of patientsTumor recurrence rateYear survival rateTargeted molecular therapiesHigh-grade gliomasAdjuvant chemotherapyPerformance statusSurgical resectionPrimary outcomeRecurrence rateSingle institutionExcellent survivalSpinal cordPatientsAssociation scoreGrade gliomasSurvival rate